Johnson & White Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Johnson & White Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,833	Closed	-$642K	–	52
2024 Q1	$642K	Buy	11,833 +2,612	+28%	+$133K	0.47%	52
2023 Q4	$473K	Sell	9,221 -1,598	-15%	-$83.9K	0.39%	53
2023 Q3	$628K	Buy	+10,819	New	+$663K	0.57%	45
2023 Q2	–	Sell	-10,417	Closed	-$722K	–	42
2023 Q1	$722K	Buy	+10,417	New	+$735K	0.64%	36
2022 Q4	–	Sell	-10,635	Closed	-$756K	–	83
2022 Q3	$756K	Buy	+10,635	New	+$771K	0.85%	29

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Johnson & White Wealth Management's BMY Position: Q2 2024 in Review

Johnson & White Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 11,833 shares — an estimated $642K sold.

Johnson & White Wealth Management first reported a position in BMY in Q3 2022 and held it in 5 quarters. The position peaked at $756K in Q3 2022. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Johnson & White Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
Johnson & White Wealth Management sold 11,833 Bristol-Myers Squibb shares in Q2 2024, an estimated $642K.
Johnson & White Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2022 and held it in 5 quarters.
Johnson & White Wealth Management's Bristol-Myers Squibb position peaked at $756K in Q3 2022.
2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Johnson & White Wealth Management's 13F filing for Q2 2024, filed 19 Jul 2024.